Chemed (CHE) Declares $0.38 Dividend
Chemed said on May 15, 2023 that its board of directors declared a regular quarterly dividend of $0.38 per share ($1.52 annualized). Previously, the company paid $0.38 per share.
Shares must be purchased before the ex-div date of May 24, 2023 to qualify for the dividend. Shareholders of record as of May 25, 2023 will receive the payment on June 14, 2023.
At the current share price of $544.03 / share, the stock's dividend yield is 0.28%.
Looking back five years and taking a sample every week, the average dividend yield has been 0.31%, the lowest has been 0.24%, and the highest has been 0.45%. The standard deviation of yields is 0.04 (n=237).
The current dividend yield is 0.81 standard deviations below the historical average.
Additionally, the company's dividend payout ratio is 0.09. The payout ratio tells us how much of a company's income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company's income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.
The company's 3-Year dividend growth rate is 0.19%, demonstrating that it has increased its dividend over time.
Learn to Harvest Dividends
Buy Stock. Capture Dividend. Sell Stock. Repeat. This is the essence of dividend harvesting and you can do it easily with Fintel's Dividend Capture Calendar.
What is the Fund Sentiment?
There are 970 funds or institutions reporting positions in Chemed. This is an increase of 11 owner(s) or 1.15% in the last quarter. Average portfolio weight of all funds dedicated to CHE is 0.33%, an increase of 3.87%. Total shares owned by institutions increased in the last three months by 0.45% to 17,073K shares. 
The put/call ratio of CHE is 0.33, indicating a bullish outlook.
Analyst Price Forecast Suggests 12.03% Upside
As of May 11, 2023, the average one-year price target for Chemed is 609.45. The forecasts range from a low of 565.60 to a high of $640.50. The average price target represents an increase of 12.03% from its latest reported closing price of 544.03.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Chemed is 2,234MM, an increase of 3.21%. The projected annual non-GAAP EPS is 20.41.
What are Other Shareholders Doing?
William Blair Investment Management holds 561K shares representing 3.75% ownership of the company. In it's prior filing, the firm reported owning 502K shares, representing an increase of 10.55%. The firm increased its portfolio allocation in CHE by 7.28% over the last quarter.
Neuberger Berman Group holds 533K shares representing 3.56% ownership of the company. In it's prior filing, the firm reported owning 539K shares, representing a decrease of 1.13%. The firm decreased its portfolio allocation in CHE by 49.68% over the last quarter.
Kayne Anderson Rudnick Investment Management holds 510K shares representing 3.41% ownership of the company. In it's prior filing, the firm reported owning 513K shares, representing a decrease of 0.57%. The firm decreased its portfolio allocation in CHE by 31.39% over the last quarter.
Envestnet Asset Management holds 478K shares representing 3.19% ownership of the company. In it's prior filing, the firm reported owning 52K shares, representing an increase of 89.19%. The firm decreased its portfolio allocation in CHE by 6.79% over the last quarter.
IJH - iShares Core S&P Mid-Cap ETF holds 459K shares representing 3.07% ownership of the company. In it's prior filing, the firm reported owning 436K shares, representing an increase of 5.15%. The firm increased its portfolio allocation in CHE by 7.59% over the last quarter.
Chemed Background Information
(This description is provided by the company.)
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.
Key filings for this company:
This story originally appeared on Fintel.